Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes

Abdel-Kémal Bori Bata; Amadou Gabriel Ciss; Momar Sokhna Diop; Papa Salmane Ba; Diagne Papa Amath; Ndeye Fatou Sow; Gaye Magaye; Souleyman Diatta; Mohamed Leye; Etienne Birame Sene; Papa Adama Dieng; Salimata Diallo; Assane Ndiaye; Mouhamadou Ndiaye

doi:doi:10.11648/j.ccr.20180201.14

Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes

Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, Ndeye Fatou Sow, Gaye Magaye, Souleyman Diatta, Mohamed Leye, Etienne Birame Sene, Papa Adama Dieng, Salimata Diallo, Assane Ndiaye, Mouhamadou Ndiaye

Published in Cardiology and Cardiovascular Research (Volume 2, Issue 1)

Received: 12 December 2017 Accepted: 24 February 2018 Published: 10 April 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.

Published in	Cardiology and Cardiovascular Research (Volume 2, Issue 1)
DOI	10.11648/j.ccr.20180201.14
Page(s)	15-18
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Cardiac Surgery, Mitral Valve Replacement, West Africa, Outcomes

References

[1]	Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, Damorou JM, Ndobo P, et al. The Valvafric study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016; 109 (5):321-9.
[2]	Balaka A, Tchamdja T, Djibril MA, Djagadou KA, Tchandana M, Damorou F, Agbétra A. Valvular heart disease in hospitals in Lome (Togo). Pan Afr Med J. 2015; 20:168.
[3]	Zilla P, Koshy J, Brink J, Human P. Mitral valve replacement for rheumatic heart disease in Southern Africa. Journal of Cardiothoracic Surgery. 2013; 8 (Suppl 1):O294. doi:10.1186/1749-8090-8-S1-O294.
[4]	Leguerrier A, Flecher E, Fouquet O, Lelong B. Prothèses valvulaires cardiaques. EMC – Cardiologie. 2009; 30:1-31.
[5]	Nwiloh JO, Oludara MA, Adebola PA, Edaigbini, SA, Danbauchi S, Sowunmi AC. Experience with prosthetic valve replacement in indigents with rheumatic heart disease in Nigeria: 10-Year Follow-Up. World J Cardiovasc Surg. 2015; 5 (08):75.
[6]	Yangni-Angate KH, Meneas C, Diby F, Diomande M, Adoubi A, Tanauh Y. Cardiac surgery in Africa: a thirty-five-year experience on open heart surgery in Cote d'Ivoire. Cardiovasc Diagn Ther. 2016; 6 (1):44-63.
[7]	Edwin F, Aniteye E, Tettey MM, Tamatey M, Frimpong-Boateng K. Outcome of left heart mechanical valve replacement in West African children - a 15-year retrospective study. J Cardiothorac Surg. 2011; 6:57.
[8]	Samiei N, Hakimi MR, Mirmesdagh Y, Peighambari MM, Alizadeh-Ghavidel A, Hosseini S. Surgical outcomes of heart valves replacement: A study of tertiary specialied cardiac center. ARYA Atherosclerosis. 2014; 10 (5):233-237.
[9]	Bourguignon T, Bergöend E, Mirza A, Ayegnon G, Neville P, Aupart MR, Marchand M. Risk factors for valve-related complications after mechanical heart valve replacement in 505 patients with long-term follow up. J Heart Valve Dis. 2011; 20 (6):673-80.
[10]	Mvondo CM, Pugliese M, Giamberti A, Chelo D, Kuate LM, Boombhi J, Dailor EM. Surgery for rheumatic mitral valve disease in sub-saharan African countries: why valve repair is still the best surgical option. Pan Afr Med J. 2016; 24:307.
[11]	Zouaoui W, Ouldzein H, Drissa MA, Essafi N, Meddeb I, Drissa H. [Short- and long-term results of mitral valve replacement by caged-ball and bileaflet mechanical prosthesis (series of 236 consecutive patients with average follow-up of 11 years)]. Ann Cardiol Angeiol. 2009; 58 (2):86-93.
[12]	Benedetto U, Melina G, Angeloni E, Refice S, Roscitano A, Comito C, Sinatra R. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J of Thorac and Cardiovasc Surg. 2012; 143 (3): 632-638.
[13]	Rezahosseini O, Rezaei M, Ahmadi Tafti SH, Jalali A, Bina P, Ghiasi A, Karimi A, Abbasi K, Shirzad M, Davoodi S, Salehi Omran A. Transseptal Approach versus Left Atrial Approach to Mitral Valve: A Propensity Score Matching Study. J Tehran Heart Cent. 2015; 10 (4):188-93.
[14]	Al Mosa AF, Omair A, Arifi AA, Najm HK. Mitral valve replacement for mitral stenosis: A 15-year single center experience. J Saudi Heart Assoc. 2016; 28 (4):232-8.
[15]	Takano H, Hiramatsu M, Kida H, Uenoyama M, Horiguchi K, Yamauchi T, Kin K, Shirakawa Y, Kaneko M, Daimon T. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today. 2017; 47 (4):445-456.

Cite This Article

Plain Text BibTeX RIS

APA Style

Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. (2018). Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiology and Cardiovascular Research, 2(1), 15-18. https://doi.org/10.11648/j.ccr.20180201.14

Copy | Download

ACS Style

Abdel-Kémal Bori Bata; Amadou Gabriel Ciss; Momar Sokhna Diop; Papa Salmane Ba; Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol. Cardiovasc. Res. 2018, 2(1), 15-18. doi: 10.11648/j.ccr.20180201.14

Copy | Download

AMA Style

Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol Cardiovasc Res. 2018;2(1):15-18. doi: 10.11648/j.ccr.20180201.14

Copy | Download

@article{10.11648/j.ccr.20180201.14,
  author = {Abdel-Kémal Bori Bata and Amadou Gabriel Ciss and Momar Sokhna Diop and Papa Salmane Ba and Diagne Papa Amath and Ndeye Fatou Sow and Gaye Magaye and Souleyman Diatta and Mohamed Leye and Etienne Birame Sene and Papa Adama Dieng and Salimata Diallo and Assane Ndiaye and Mouhamadou Ndiaye},
  title = {Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes},
  journal = {Cardiology and Cardiovascular Research},
  volume = {2},
  number = {1},
  pages = {15-18},
  doi = {10.11648/j.ccr.20180201.14},
  url = {https://doi.org/10.11648/j.ccr.20180201.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20180201.14},
  abstract = {The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.},
 year = {2018}
}

Copy | Download

TY - JOUR
T1 - Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes
AU - Abdel-Kémal Bori Bata
AU - Amadou Gabriel Ciss
AU - Momar Sokhna Diop
AU - Papa Salmane Ba
AU - Diagne Papa Amath
AU - Ndeye Fatou Sow
AU - Gaye Magaye
AU - Souleyman Diatta
AU - Mohamed Leye
AU - Etienne Birame Sene
AU - Papa Adama Dieng
AU - Salimata Diallo
AU - Assane Ndiaye
AU - Mouhamadou Ndiaye
Y1 - 2018/04/10
PY - 2018
N1 - https://doi.org/10.11648/j.ccr.20180201.14
DO - 10.11648/j.ccr.20180201.14
T2 - Cardiology and Cardiovascular Research
JF - Cardiology and Cardiovascular Research
JO - Cardiology and Cardiovascular Research
SP - 15
EP - 18
PB - Science Publishing Group
SN - 2578-8914
UR - https://doi.org/10.11648/j.ccr.20180201.14
AB - The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.
VL - 2
IS - 1
ER -

Copy | Download

Author Information

Abdel-Kémal Bori Bata

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Amadou Gabriel Ciss

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Momar Sokhna Diop

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Papa Salmane Ba

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Diagne Papa Amath

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Ndeye Fatou Sow

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Gaye Magaye

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Souleyman Diatta

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Mohamed Leye

Department of Cardiology FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Etienne Birame Sene

Department of Anesthesiology FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Papa Adama Dieng

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Salimata Diallo

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Assane Ndiaye

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal
Mouhamadou Ndiaye

Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. (2018). Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiology and Cardiovascular Research, 2(1), 15-18. https://doi.org/10.11648/j.ccr.20180201.14

Copy | Download

ACS Style

Abdel-Kémal Bori Bata; Amadou Gabriel Ciss; Momar Sokhna Diop; Papa Salmane Ba; Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol. Cardiovasc. Res. 2018, 2(1), 15-18. doi: 10.11648/j.ccr.20180201.14

Copy | Download

AMA Style

Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol Cardiovasc Res. 2018;2(1):15-18. doi: 10.11648/j.ccr.20180201.14

Copy | Download

@article{10.11648/j.ccr.20180201.14,
  author = {Abdel-Kémal Bori Bata and Amadou Gabriel Ciss and Momar Sokhna Diop and Papa Salmane Ba and Diagne Papa Amath and Ndeye Fatou Sow and Gaye Magaye and Souleyman Diatta and Mohamed Leye and Etienne Birame Sene and Papa Adama Dieng and Salimata Diallo and Assane Ndiaye and Mouhamadou Ndiaye},
  title = {Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes},
  journal = {Cardiology and Cardiovascular Research},
  volume = {2},
  number = {1},
  pages = {15-18},
  doi = {10.11648/j.ccr.20180201.14},
  url = {https://doi.org/10.11648/j.ccr.20180201.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20180201.14},
  abstract = {The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.},
 year = {2018}
}

Copy | Download